Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.
Immune checkpoint inhibitor target found to promote skin cancer growth
- Post author:
- Post published:January 19, 2024
- Post category:uncategorized